论文部分内容阅读
目的探讨在临床急诊内科中治疗老年重症心力衰竭的临床疗效。方法回顾性分析100例急诊内科老年重症心力衰竭患者的临床资料,将其随机分为实验组与对照组,每组50例。对照组患者给予常规临床保守治疗,实验组患者在对照组的基础上给予美托洛尔联合及厄贝沙坦氢氯噻嗪进行治疗。治疗结束后对两组患者的临床疗效进行综合评价分析。结果治疗12周后,实验组临床治疗总有效率为90.0%,高于对照组的66.0%,差异具有统计学意义(P<0.01)。结论对急诊内科老年重症心力衰竭患者在临床治疗中应用美托洛尔联合厄贝沙坦氢氯噻嗪进行治疗得到了较为理想的临床效果,能够明显的改善患者的临床不适症状,并且该方法的临床疗效稳定,对提高患者的预后具有重要意义。
Objective To investigate the clinical efficacy of treating acute severe heart failure in clinical emergency department. Methods A retrospective analysis of 100 cases of elderly patients with severe heart failure clinical data, were randomly divided into experimental group and control group, 50 cases in each group. Patients in the control group were given routine clinical conservative treatment. Patients in the experimental group were treated with metoprolol combined with irbesartan hydrochlorothiazide on the basis of the control group. After treatment, the clinical efficacy of the two groups were evaluated comprehensively. Results After 12 weeks of treatment, the total effective rate of clinical trial in experimental group was 90.0%, which was higher than that in control group (66.0%), the difference was statistically significant (P <0.01). Conclusion The clinical application of metoprolol combined with irbesartan hydrochlorothiazide in the treatment of elderly patients with severe heart failure in emergency department has achieved satisfactory clinical results, which can significantly improve the clinical symptoms of patients and the clinical efficacy of the method Stable, to improve the prognosis of patients with great significance.